poorly soluble drugs through the integration of nanocrystal and cocrystal technologies
A novel solubilization technique for
poorly soluble drugs through the PRAYAS ACHARYA integration of nanocrystal and cocrystal technologies. A novel solubilization technique for poorly soluble drugs through the PRAYAS ACHARYA integration of nanocrystal and cocrystal technologies. Research Methodo Primary literature
1.The solubility of the poorly soluble
drugs can be increased by nano-cocrystal technologies
1)N. Blagden, M. de Matas, P.T. Gavan, P.
York, Crystal engineering of active pharmaceutical ingredients to improve solubility and dissolution rates, Adv. Drug Deliv. Rev. 59 (2007) 617–630 2.The optimal selection of cocrystals and concentration of stabilizers are key factors in the design of nano-cocrystal formulations.
2)S. Basavoju, D. Boström, S.P. Velaga,
Indomethacin–saccharin cocrystal: design, synthesis and preliminary pharmaceutical characterization, Pharm. Res. 25 (2008) 530–541 3.Nano-cocrystal formulations have higher dissolution rates and saturation concentrations compared to the pure nanocrystals and cocrystals.
3)L. De Smet, L. Saerens, T. De Beer, R.
Carleer, P. Adriaensens, J. Van Bocxlaer, C. Vervaet, J.P. Remon, Formulation of itraconazole nanococrystals and evaluation of their bioavailability in dogs, Eur. J. Pharm. Biopharm. 87 (2014) 107–113. 4. The dissolution profiles of furosemide nanocrystal suspension and furosemide- caffeine nano-cocrystal suspension
4)N.H. Chun, I.C. Wang, M.J. Lee, Y.T. Jung,
S. Lee, W.S. Kim, G.J. Choi, Characteristics of indomethacin–saccharin (IMC–SAC) co-crystals prepared by an anti-solvent crystallization process, Eur. J. Pharm. Biopharm. 85 (2013) 854–861. 5.In stability study,the nano-cocrystal suspensions are physically and chemically stable for atleast one month at room temperature
5)E. Baka, J.E. Comer, K. Takács-Novák,
Study of equilibrium solubility measurement by saturation shake-flask method using hydrochlorothiazide as model compound, J. Pharm. Biomed. Anal. 46 (2) (2008) 335–341. 6)M. George, I. Ghosh, Identifying the correlation between drug/stabilizer properties and critical quality attributes (CQAs) of nanosuspension formulation prepared by wet media milling technology, Eur. J. Pharm. Sci. 48 (2013) 142–152 ch Methodology References
Primary literature
1) S. Di Maio, R.L. Carrier,
Gastrointestinal contents in fasted state and post-lipid ingestion: in vivo measurements and in vitro models for studying oral drug delivery, J. Control. Release 151 (2011) 110–122 2) C. Brough, R.O. Williams III, Amorphous solid dispersions and nano- crystal technologies for poorly water-soluble drug delivery, Int. J. Pharm. 453 (2013) 157–166 3) N. Shan, M.J. Zaworotko, The role of cocrystals in pharmaceutical science, Drug Discov. Today 13 (2008) 440–446 ogy References
Secondary literature
Roop K. Khar, SP Vyas, Farhan J Ahmad, Gaurav K Jain,